Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer is a research paper published in JCI Insight (2020). On theSindex it has a DataRank of 1.1. It has been cited 35 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Base Score Contribution
0.538
From this paper's citation signal
Citation Network Contribution
0.535
From 27 citing papers with measurable signal
Ranked by each citer's contribution to N(p) β log1p(Cq) divided by its reference count β out of 32 citers.
NIH, NCI, Sidney Kimmel Comprehensive Cancer Center, NHLBI
Grant: R01 CA169702,P50 CA062924,R01 CA197296,P30 CA006973,1K08HL108346-01
NCI NIH HHS
Grant: P30 CA006973
NCI NIH HHS
Grant: P50 CA062924
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: R01 CA169702
NCI NIH HHS
Grant: R01 CA197296
FWCI
1.58
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals